Published in BMC Health Serv Res on July 17, 2014
The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation. PLoS One (2016) 0.79
Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark. Sci Rep (2016) 0.79
Evaluating the Initiation of Novel Oral Anticoagulants in Medicare Beneficiaries. J Manag Care Spec Pharm (2016) 0.75
Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients. J Am Heart Assoc (2017) 0.75
Comorbidity measures for use with administrative data. Med Care (1998) 46.67
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA (2001) 16.98
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation (2011) 6.48
Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.88
Pharmacy benefits and the use of drugs by the chronically ill. JAMA (2004) 5.56
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol (2011) 5.06
Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ (2001) 4.66
Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med (2010) 4.15
Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation (2003) 2.61
The use of dabigatran in elderly patients. Arch Intern Med (2011) 2.43
Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care (2005) 2.33
Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. Stroke (2000) 2.29
Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation? J Gen Intern Med (1996) 2.13
Bleeding risk with dabigatran in the frail elderly. N Engl J Med (2012) 1.99
Racial and ethnic disparities in the use of cardiovascular procedures: associations with type of health insurance. Am J Public Health (1997) 1.97
Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making. Med Decis Making (2005) 1.68
Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children. Arch Gen Psychiatry (2005) 1.30
Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission. Stroke (2000) 1.15
Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol (2006) 1.13
The estimation power of alternative comorbidity indices. Value Health (2008) 1.09
Cardiology or primary care for heart failure in the community setting: process of care and clinical outcomes. Chest (1999) 1.05
Racial and insurance disparities in hospital mortality for children undergoing congenital heart surgery. Pediatr Cardiol (2012) 1.04
Adoption of new drugs by physicians: a survival analysis. BMC Health Serv Res (2012) 0.92
Factors influencing doctors' selection of dabigatran in non-valvular atrial fibrillation. J Eval Clin Pract (2012) 0.90
Is new drug prescribing in primary care specialist induced? BMC Health Serv Res (2009) 0.87
Utilization of preventive care services and their effect on cardiovascular outcomes in the United States. Risk Manag Healthc Policy (2011) 0.85
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med (2010) 4.87
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56
ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2012) 4.45
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med (2004) 3.78
Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA (2004) 3.48
Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J (2005) 3.26
Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! J Am Coll Cardiol (2012) 2.93
Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol (2010) 2.86
Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation (2012) 2.54
Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation (2008) 2.53
Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol (2010) 2.49
Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation (2003) 2.45
Long-term follow-up of coronary artery disease presenting in young adults. J Am Coll Cardiol (2003) 2.30
Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients. JAMA (2011) 2.29
Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr (2007) 2.17
Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation (2011) 2.08
Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int (2003) 2.04
Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis (2005) 2.02
Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol (2006) 1.98
Understanding the pathophysiology of apical ballooning syndrome: a step closer. Expert Rev Cardiovasc Ther (2014) 1.97
Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). J Am Coll Cardiol (2013) 1.86
Sex differences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality in younger women. Circulation (2002) 1.85
Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. Am Heart J (2012) 1.84
Patient health status and costs in heart failure: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS). Circulation (2009) 1.82
Insomnia and the performance of US workers: results from the America insomnia survey. Sleep (2011) 1.77
Trials and tribulations of non-inferiority: the ximelagatran experience. J Am Coll Cardiol (2005) 1.75
Neuropsychological outcome after percutaneous coronary intervention or coronary artery bypass grafting: results from the Stent or Surgery (SoS) Trial. Circulation (2004) 1.73
Coronary stent restenosis in patients treated with cilostazol. Circulation (2005) 1.73
Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med (2006) 1.65
Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis. Adv Ther (2010) 1.64
Prognostic value of health status in patients with heart failure after acute myocardial infarction. Circulation (2004) 1.63
Hemorrhagic and thrombotic events associated with generic substitution of warfarin in patients with atrial fibrillation: a retrospective analysis. Ann Pharmacother (2011) 1.61
The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol (2006) 1.59
Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. J Am Coll Cardiol (2011) 1.58
The relationship between B-type natriuretic peptide and health status in patients with heart failure. J Card Fail (2005) 1.58
Angiographic disease progression and residual risk of cardiovascular events while on optimal medical therapy: observations from the COURAGE Trial. Circ Cardiovasc Interv (2011) 1.56
A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol (2002) 1.54
Predicting cardiovascular events with coronary calcium scoring. N Engl J Med (2008) 1.53
Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeks. J Am Coll Cardiol (2004) 1.52
The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial. Am J Cardiol (2006) 1.47
Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary intervention. J Interv Cardiol (2009) 1.47
Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch Intern Med (2006) 1.47
Relationship between procedure indications and outcomes of percutaneous coronary interventions by American College of Cardiology/American Heart Association Task Force Guidelines. Circulation (2005) 1.47
Risk of local adverse events following cardiac catheterization by hemostasis device use and gender. J Invasive Cardiol (2004) 1.47
Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol (2003) 1.47
Economic outcome of cardiac CT-based evaluation and standard of care for suspected acute coronary syndrome in the emergency department: a decision analytic model. Acad Radiol (2011) 1.45
Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era. Am Heart J (2003) 1.44
Long-term follow-up of polytetrafluoroethylene-covered stents implanted during percutaneous coronary intervention for management of acute coronary perforation. Catheter Cardiovasc Interv (2011) 1.44
Many Americans have pre-diabetes and should be considered for metformin therapy. Diabetes Care (2009) 1.43
Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial. Circ Cardiovasc Qual Outcomes (2009) 1.43
Linking the National Cardiovascular Data Registry CathPCI Registry with Medicare claims data: validation of a longitudinal cohort of elderly patients undergoing cardiac catheterization. Circ Cardiovasc Qual Outcomes (2012) 1.42
A longitudinal assessment of coronary interventional program quality: a report from the American College of Cardiology-National Cardiovascular Data Registry. JACC Cardiovasc Interv (2009) 1.41
Cardiovascular risk factors one year after a hypertensive disorder of pregnancy. J Womens Health (Larchmt) (2014) 1.40
The importance of cardiorespiratory fitness in the United States: the need for a national registry: a policy statement from the American Heart Association. Circulation (2013) 1.37
Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. J Am Coll Cardiol (2002) 1.35
Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease. Circulation (2005) 1.34
The American Heart Association's principles for comparative effectiveness research: a policy statement from the American Heart Association. Circulation (2009) 1.33
Time course of depression and outcome of myocardial infarction. Arch Intern Med (2006) 1.30
Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2. J Gen Intern Med (2008) 1.28
Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. Am Heart J (2005) 1.27
The impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistence. J Ocul Pharmacol Ther (2009) 1.26
Utility estimates for decision-analytic modeling in chronic heart failure--health states based on New York Heart Association classes and number of rehospitalizations. Value Health (2008) 1.24
Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments. Circulation (2007) 1.24
Excessive daytime sleepiness is associated with poor medication adherence in adults with heart failure. J Card Fail (2010) 1.19
ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol (2011) 1.19
Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials. Atherosclerosis (2012) 1.19
Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). Sleep (2011) 1.19
Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol (2009) 1.18
Development of 2 registry-based risk models suitable for characterizing hospital performance on 30-day all-cause mortality rates among patients undergoing percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes (2012) 1.17
Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial. J Am Coll Cardiol (2009) 1.15
Endothelial function and aminothiol biomarkers of oxidative stress in healthy adults. Hypertension (2008) 1.15
Multicenter experience in revascularization of very elderly patients. Am Heart J (2004) 1.15
Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment. Circulation (2005) 1.15
Importance of side effects in opioid treatment: a trade-off analysis with patients and physicians. J Pain (2010) 1.13
Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension (2002) 1.12
Persistence with oral naltrexone for alcohol treatment: implications for health-care utilization. Addiction (2008) 1.12
Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. J Am Coll Cardiol (2002) 1.11
Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv (2013) 1.10
Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes). J Am Coll Cardiol (2013) 1.10
Acceptance, panic, and partial recovery the pattern of usage of drug-eluting stents after introduction in the U.S. (a report from the American College of Cardiology/National Cardiovascular Data Registry). JACC Cardiovasc Interv (2010) 1.09
Reliability and validity of the brief insomnia questionnaire in the America insomnia survey. Sleep (2010) 1.08
Outcome of patients with acute coronary syndrome admitted to hospitals with or without onsite cardiac catheterization laboratory: a TACTICS-TIMI 18 substudy. Crit Pathw Cardiol (2002) 1.08
Coronary artery calcium and cardiac events: is electron-beam tomography ready for prime time? Circulation (2003) 1.07
The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey. Arch Gen Psychiatry (2012) 1.07
Percutaneous coronary interventions in facilities without cardiac surgery on site: a report from the National Cardiovascular Data Registry (NCDR). J Am Coll Cardiol (2009) 1.07